Table 1.
Baseline clinical characteristics of the study population
| Characteristics | SAP (n = 12) | UAP (n = 15) | p Value |
| Age (years) | 63 (3) | 63 (2) | 0.97 |
| Male/female | 11/1 | 14/1 | >0.99 |
| Systemic hypertension | 3 | 9 | 0.12 |
| Hyperlipidaemia* | 4 | 8 | 0.44 |
| Hyperuricaemia | 2 | 2 | >0.99 |
| Diabetes mellitus | 4 | 6 | >0.99 |
| Smoker | 3 | 6 | 0.68 |
| Obesity† | 2 | 4 | 0.66 |
| Family history‡ | 1 | 2 | >0.99 |
| Culprit lesion (narrowing >50%) | |||
| LAD | 10 | 13 | |
| LMT | 2 | 0 | |
| RCA | 0 | 2 | 0.39 |
| Aspirin | 12 | 15 | >0.99 |
| Statins | 3 | 5 | 0.70 |
Values are mean (SEM) or n.
*Previous diagnosis of hyperlipidaemia or patient on lipid lowering therapy
†Body mass index >30 kg/m2.
‡A parent, sibling, or child with a history of coronary artery disease.
LAD, left anterior descending coronary artery; LMT, left main trunk; RCA, right coronary artery; SAP, stable angina pectoris; UAP, unstable angina pectoris.